Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 308 Indirect treatment compari...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

Bibliographic Details
Main Authors: Dirk Schadendorf, Mark Middleton, Jeffrey Weber, Delphine Hennicken, Paolo Ascierto, Andriy Moshyk, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
    by: Hemstock, M, et al.
    Published: (2020)
  • Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis
    by: Kabirraaj Toor, et al.
    Published: (2021-01-01)
  • Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    by: Ravi Potluri, et al.
    Published: (2019-07-01)
  • Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
    by: Bruno Bregman, et al.
    Published: (2020-09-01)
  • Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
    by: Wolfram Samlowski, et al.
    Published: (2023-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs